Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

1.2K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.2K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

243
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
243
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

122
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
122
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

148
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
148
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

102
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
102
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

89
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
89

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Silicone stent placement for laryngeal diseases: a retrospective study of 14 dogs (2022-2025).

The Journal of small animal practice·2026
Same author

Cardiac angiosarcoma.

Acta cardiologica·2025
Same author

Versatile multi-energy hard x-ray camera to study confined and unconfined fast electron dynamics and anisotropies (Invited).

The Review of scientific instruments·2024
Same author

Evidence of Electron Heating by Alpha Particles in JET Deuterium-Tritium Plasmas.

Physical review letters·2023
Same author

Comments on association of HbA1c with carotid artery plaques in patients with coronary heart disease.

Acta cardiologica·2023
Same author

[Design, implementation and evaluation of an educational approach for patients with PICC line and midline].

Annales pharmaceutiques francaises·2023

Related Experiment Video

Updated: Nov 18, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.9K

[Cardiogenic shock : etiology and management].

R Dumont1, J Tridetti1, A Ancion1

  • 1Service de Cardiologie, CHU Liège, Belgique.

Revue Medicale De Liege
|February 5, 2021
PubMed
Summary

Cardiogenic shock, a severe circulatory issue often stemming from heart attacks, leads to organ damage and has a high mortality rate. Prompt treatment with coronary revascularization and supportive care is crucial for survival.

Keywords:
Cardiogenic shockHeart TeamMyocardial infarctionIntensive care

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.5K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

23.1K

Related Experiment Videos

Last Updated: Nov 18, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.9K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.5K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

23.1K

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock is a life-threatening circulatory shock type characterized by organ hypoperfusion and potential multivisceral failure.
  • It carries a high mortality rate, approaching 50%, highlighting the critical nature of this condition.
  • While often secondary to acute myocardial infarction (80% of cases), it complicates only 5-10% of heart attacks, particularly in multi-vessel coronary artery disease.

Framework:

  • Understanding cardiogenic shock involves recognizing its distinct pathophysiology within the broader spectrum of circulatory shock.
  • Identifying risk factors, such as severe coronary artery disease, is key to early diagnosis and intervention.
  • The condition necessitates a multidisciplinary approach for effective management.

Implementation:

  • Primary treatment strategies focus on coronary revascularization to restore blood flow to the ischemic myocardium.
  • Supportive care is essential, encompassing hemodynamic stabilization and organ support.
  • Early recognition and timely intervention are critical for improving patient outcomes.

Implications:

  • Effective management of cardiogenic shock can significantly reduce mortality rates and improve long-term prognosis.
  • Advances in treatment strategies, including revascularization techniques and supportive therapies, are vital for patient survival.
  • Further research into predicting and preventing cardiogenic shock in high-risk populations is warranted.